Bristol Meyers Squibb Laboratories Co. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Bristol Meyers Squibb Laboratories Co.

Sort by

Viewing results 1‒25 of 637

LexPharmaceuticals sector
Big Pharma still needs trial success to overcome looming patent panic Premium content
...Still, that has not stopped investors from fretting about pipeline replacement at companies such as Bristol Myers Squibb (BMS), Sanofi and Roche....
February 6, 2024
LexEli Lilly & Co
Eli Lilly’s heavyweight status looks set to last Premium content
...Bristol Myers Squibb trades on just seven times earnings while Pfizer is on 20 times. The frenzy for weight loss and diabetes medications is unlikely to fade....
January 16, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Deepmind Technologies Ltd
DeepMind spin-off aims to halve drug discovery times following Big Pharma deals
...Oxford-based Exscientia is working with Sanofi and Bristol Myers Squibb, among others, and Insitro has a deal with Bristol Myers, while Owkin is also collaborating with Sanofi....
January 10, 2024
The Week Ahead
Opening arguments begin in Trump trial
...Stock Exchange Group AGM and Q1 trading statement (revenues only), Merck & Co Q1, Microsoft Q3, Nestlé Q1 sales figures, Northrop Grumman Q1, Persimmon AGM and trading update, Porsche Q1, Royal Caribbean...
April 21, 2024
On Wall StreetJames Fontanella-Khan
Banks hope for M&A revival despite the geopolitics
...In the pharmaceutical industry, big companies including AstraZeneca, AbbVie and Bristol Myers Squibb have announced about $25bn worth of biotech-related deals....
January 13, 2024
The Week Ahead
Groundhog Day rings true for US politics
...Myers Squibb Q4, Charter Communications Q4, Chevron Q4, Cigna Group Q4, Danske Bank Q4, Deutsche Bank FY, Electrolux Q4, ExxonMobil Q4, Ferrari Q4, Japan Airlines Q3, KDDI Q3, Mitsui & Co Q3, Panasonic...
January 28, 2024
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
FirstFT
FirstFT: Meta rewards investors with first dividend and $50bn buyback
...Pharmaceutical groups Bristol Myers Squibb, Regeneron and AbbVie are also expected to release earnings....
February 2, 2024
US politics & policy
US targets 10 drugs for pricing negotiations in crackdown on costs
...Myers Squibb; and a Novartis drug to treat heart failure called Entresto....
August 29, 2023
Drug prices
Bristol Myers Squibb warns US price reforms will dent drug development
...Bristol Myers Squibb says it expects to cancel some drug development programmes due to US government drug pricing rules that are due to be phased in from next year....
November 20, 2022
Drug prices
Bristol Myers Squibb warns UK medicines levy threatens investment
...The chief executive of Bristol Myers Squibb has warned that the US pharmaceutical company could divert investment away from the UK due to the expansion of a levy designed to limit the NHS’s medicines bill...
November 13, 2022
Due Diligence
Meet Metro Bank’s new billionaire owner Premium content
...Myers Squibb to acquire Mirati in up to $5.8bn deal (Reuters) German auto group Schaeffler swoops for Vitesco with €3bn bid (FT) Big banks sit out LBO rebound after being stung by earlier buyouts (FT)...
October 10, 2023
The Week Ahead
Fed, ECB and BoJ set rates, Big Tech earnings in spotlight
...Myers Squibb Q2, Britvic Q3 trading statement, BT Group Q1 trading update, Groupe Casino H1, Centrica H1, CMC Markets Q1 trading update, Comcast Q2, CVS Group trading update, EDF H1, Elementis H1, Ford...
July 23, 2023
Interiors
The return of the unfitted kitchen
...For her own kitchen in a Bristol apartment, Cox opted for a country-house feel, “a mix and match of things; with the slight sense of disorder that I find pleasing.”...
October 13, 2023
Bristol-Myers Squibb Co
Bristol-Myers Squibb to acquire cancer drugmaker Turning Point for $4.1bn
...Bristol-Myers Squibb has agreed to acquire Turning Point Therapeutics for $4.1bn in the latest in a series of bolt-on acquisitions by pharmaceutical companies looking to bolster their drug pipelines....
June 3, 2022
The Big Read
How a Swedish start-up reignited the search for an Alzheimer’s drug
...GSK, Pfizer and Bristol Myers Squibb were among other big pharmaceutical companies that stopped trying to find treatments for some of humanity’s most inscrutable diseases....
July 3, 2023
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
Drug prices
US drugmakers withdraw from NHS pricing agreement as costs soar
...Last year, US drugmaker Bristol Myers Squibb said it could divert investment away from the UK because of the increasing clawbacks....
January 16, 2023
Pharmaceuticals sector
Big Pharma fights patent disclosure demand from investors
...A coalition of ethical investors have asked Johnson & Johnson, Merck, Pfizer, Eli Lilly, Gilead, Amgen, Regeneron, Bristol Myers Squibb and AbbVie to publish a report on the process they follow when applying...
February 26, 2023
BioNTech
BioNTech buys UK AI start-up InstaDeep in £562mn deal
...Sanofi and Bristol Myers Squibb are among those that have struck partnerships with AI-focused start-ups but an acquisition is unusual....
January 10, 2023
The Big Read
The Biden administration takes on the US drugs industry
...Cancer, stroke and diabetes medications made by Merck, Johnson & Johnson and Bristol Myers Squibb are among the first tranche of medications selected for negotiation....
September 18, 2023
Biotech
Investors bet on AI start-ups to turbocharge drug development
...Bristol Myers Squibb already signed a $1.2bn deal with AI company Exscientia last year, and both Owkin and Exscientia recently signed partnerships with French drugmaker Sanofi....
June 11, 2022
The Week Ahead
Nato boss seeks to strengthen Asian alliances
...Myers Squibb Q4, BT Group Q3 trading update, Canada Goose Q3, Chubb Q4, ConocoPhillips Q4, Danske Bank Q4, Dassault Systemes Q4, Deutsche Bank FY, Electrolux FY, Eli Lilly & Co Q4, Estee Lauder Q2, Fast...
January 29, 2023
Pharmaceuticals sector
Merck in talks over $40bn deal for cancer biotech SeaGen
...SeaGen also recently signed a partnership with French drugmaker Sanofi and has agreements with Takeda and Bristol Myers Squibb among others. SeaGen declined to comment....
July 7, 2022
Scientific research
How one professor moved his research to a new country — and took his laboratory, too
...After that, he adds, “Oxford was fully co-operative and let me take all my stuff.”...
May 16, 2022
Biotech
Investors hunt for biotech bargains as market shows signs of a thaw
...The conditions appear ripe for an M&A boom: big drugmakers are sitting on almost $300bn of cash and many, including Merck and Bristol-Myers-Squibb, need to refill their pipelines because of major patent...
October 26, 2022
Special ReportRegulated Markets
Pharma dealmaking hit by greater scrutiny of prices and competition
...David Elkins, chief financial officer at Bristol-Myers Squibb, says the company remained optimistic about adding to its drug pipeline and did not see a big change in the regulatory environment....
February 28, 2022

Previous pagePage 1 of 26Next page